← All Synergy Chc CORP filings

Synergy Chc CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
SNYR
Synergy Chc CORP
10-Q: Synergy CHC Corp. Q1 2026 Financials Show Revenue Decline
Synergy CHC Corp. reported a significant decrease in revenue for the first quarter of 2026, driven by lower product sales, alongside an increased net loss.
NASDAQ
SNYR
Synergy Chc CORP
10-Q: Synergy CHC Q3 2025: Revenue Up, Debt Reduced, IPO Boosts Capital
Synergy CHC Corp. reported increased Q3 revenue and gross profit, significantly reduced liabilities through debt settlements and a new senior loan, and completed an IPO.
NASDAQ
SNYR
Synergy Chc CORP
10-Q: Synergy CHC Q2 Profit Soars on License Revenue, Debt Gains
Synergy CHC Corp. reported a significant increase in net income for Q2 2025, driven by new license revenue and substantial gains from debt settlements, despite a decline in product sales.
NASDAQ
SNYR
Synergy Chc CORP
10-Q: Synergy CHC Corp. Reports Net Income of $876,264 for Q1 2025, Despite Revenue Decline
Synergy CHC Corp. announces a profitable first quarter for 2025, driven by a license agreement and cost management, despite a decrease in product sales revenue.
NASDAQ
SNYR
Synergy Chc CORP
10-Q: Synergy CHC Corp. Reports Net Income of $2 Million in Q3 2024 Despite Revenue Dip
Synergy CHC Corp. reports a net income of $2.019 million for the nine months ended September 30, 2024, despite a decrease in revenue compared to the same period in 2023.